A pill typically prescribed for rheumatoid arthritis and alopecia might help slow the progression of type 1 diabetes, ...

There’s a cliché in the type 1 diabetes community that a cure has been “five years away” for as long as anyone can remember. For decades, patients have been told that researchers were on the verge of ...

Medical experts recognize type 5 diabetes as separate from other types, requiring specialized treatment focusing on ...

The oral Janus kinase inhibitor baricitinib (Olumiant) preserved beta-cell function in people with new-onset type 1 diabetes over 48 weeks, new phase 2 data show. A randomized, placebo-controlled ...

Changes recommended in clinical trial design to include the voice of more people living with type 1 diabetes in evaluating therapy benefits Decades of research have demonstrated that beta cell ...

Recently, researchers in Australia tested baricitinib, a drug used for rheumatoid arthritis, in people newly diagnosed with Type‑1 diabetes, showing promising results for early intervention.

A new experimental treatment may be able to cure type 1 diabetes. About 83% of the patients were able to stop using insulin after the treatment. Research into the treatment is ongoing. Experts explain ...

A new experimental treatment may be able to cure type 1 diabetes. About 83% of the patients were able to stop using insulin after the treatment. Research into the treatment is ongoing. Experts explain ...

Changes recommended in clinical trial design to include the voice of more people living with type 1 diabetes in evaluating therapy benefits NEW YORK, Aug. 14, 2025 /PRNewswire/ -- Breakthrough T1D, ...